See more
Podcast — Drug Pricing: How Might the Trump Administration Transform FDA Enforcement Activities?
Podcast — Drug Pricing: What’s in the New CMS Medicaid Final Rule?
Podcast — Drug Pricing: Takeaways From the Chicago Medicaid Drug Rebate Program Summit
Podcast — Drug Pricing: How the Demise of Chevron Deference and Other Litigation May Impact the Pharmaceutical Industry
Podcast — Drug Pricing: How Are Payers Responding to the IRA?
ESG Masterclass — Legal Risks Hiding in Your DEIB Programming
Public M&A Day in Frankfurt
ESG Masterclass — ESG and Impact Investing
ESG Masterclass — Empowering Women and Girls in Sparking Lasting Change
ESG Masterclass — ESG and Politics
Navigating the Impact of Counterparty Insolvency and Negative Market Conditions in the Crypto Space
Understanding NFTs and Their Legal Implications
NFTs 101: The Basics of Non-Fungible Tokens, and Beyond
Fast Track to IPO: Why Are Series A Startups Snatching Topflight CFOs?
Energy & Infrastructure: Renewables Driving Change in the Investment Landscape
Foreign Investment Controls: Are We Seeing a More Nuanced Approach to Private Equity?
Healthcare Tech: How Are Licensing Agreements Bridging the Industry Divide?
A Look Ahead at the Biden Administration’s Regulatory and Enforcement Priorities
Healthcare Tech: What Legal Pitfalls Should Tech Companies Avoid As They Jump Into Healthcare?
Crypto in the Crosshairs: What Regulatory Themes Characterized 2020?
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.
© Latham & Watkins LLP
Refine your interests »
